Christine Guntermann

Years Active: 2017-2020
Publications (10 Years): 3

Novartis Institutes for BioMedical Research

St. Bartholomew`s Hospital, Queen Mary University of London (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Novartis Institutes for BioMedical Research

Switzerland

Lab head, project team head :: Autoimmunity, Transplantation and Inflammation

Tegenero

Germany

Scientist and project manager

Babraham Institute

United Kingdom

Post-doc :: Immunology and Signalling

Dana Farber Cancer Institute

United States

Post-doc :: Tumor Immunology and AIDS

Education History

St. Bartholomew`s Hospital, Queen Mary University of London

United Kingdom

PHD :: Immunology

King`s College London

United Kingdom

BSC

Publications

Florence Ecoeur, Jessica Weiss, Simone Schleeger, Christine Guntermann
Lack of evidence for expression and function of IL-39 in human immune cells. PloS one 15 (12) (2020)
Jochem H Bernink, Yoichiro Ohne, Marcel B M Teunissen, Jingya Wang, Jincheng Wu, Lisette Krabbendam, Christine Guntermann, Richard Volckmann, Jan Koster, Sophie van Tol, Ivan Ramirez, Yashaswi Shrestha, Menno A de Rie, Hergen Spits, Xavier Romero Ros, Alison A Humbles
c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies. Nature immunology 20 (8) (2019)
Ulf Guendisch, Jessica Weiss, Florence Ecoeur, Julia Christina Riker, Klemens Kaupmann, Joerg Kallen, Samuel Hintermann, David Orain, Janet Dawson, Andreas Billich, Christine Guntermann
Pharmacological inhibition of RORγt suppresses the Th17 pathway and alleviates arthritis in vivo. PloS one 12 (11) (2017)

Christine Guntermann.css-eqlu8i{font-size:small;padding-left:4px;}